Remember the news of Rockville-based Human Genome Sciences Inc. getting scooped up by London-based GlaxoSmithKline PLC back in mid-2012?
The acquisition news was reported internationally, but the aftermath of the $3 billion buyout is not as widely known.
{iframe}http://www.bizjournals.com/washington/blog/techflash/2014/01/what-really-happens-in-the-aftermath.html?ana=e_wash_rdup&s=newsletter&ed=2014-01-24{/iframe}